Altimmune (ALT) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -723.00 |
| Dec 31, 2025 | -1,621.00 |
| Sep 30, 2025 | -1,722.00 |
| Jun 30, 2025 | -111.00 |
| Mar 31, 2025 | -1,593.00 |
| Dec 31, 2024 | -3,566.00 |
| Sep 30, 2024 | 481.00 |
| Jun 30, 2024 | -427.00 |
| Mar 31, 2024 | 1,581.00 |
| Dec 31, 2023 | 3,256.00 |
| Sep 30, 2023 | 1,119.00 |
| Jun 30, 2023 | 6,077.00 |
| Mar 31, 2023 | 4,481.00 |
| Dec 31, 2022 | 3,618.00 |
| Sep 30, 2022 | 1,347.00 |
| Jun 30, 2022 | -1,259.00 |
| Mar 31, 2022 | 751.00 |
| Dec 31, 2021 | -3,057.00 |
| Sep 30, 2021 | -2,604.00 |
| Jun 30, 2021 | -15.00 |
| Mar 31, 2021 | 946.00 |
| Dec 31, 2020 | -544.00 |
| Sep 30, 2020 | -370.00 |
| Jun 30, 2020 | -2,037.00 |
| Mar 31, 2020 | -2,043.00 |
| Jun 30, 2019 | 3,698.00 |
| Mar 31, 2019 | 2,939.00 |
| Dec 31, 2018 | 278.00 |
| Sep 30, 2018 | -2,168.00 |
| Jun 30, 2018 | -7,397.00 |
| Mar 31, 2018 | -5,466.00 |
| Dec 31, 2017 | -4,006.00 |
| Sep 30, 2017 | -2,179.00 |
| Jun 30, 2017 | 95.00 |
| Mar 31, 2017 | -1,255.00 |
| Dec 31, 2016 | 5,093.00 |
| Sep 30, 2016 | 7,751.00 |